sun pharma semaglutide Launches Generic in India | Jay Parkhe posted on the topic Sun Pharma receives approval to

Assess at Steady-State Dose Once a stable maintenance dose is reached, heart rate typically plateaus within 46 weeks

[15][16] States that cut coverage due to cost (like California and North Carolina) may reconsider with lower pricing

It's your right, as a passenger

The GLP-1 segment recorded 177% sales growth on a moving annual turnover basis to 1,446 crore in February 2026, with Eli Lilly's Mounjaro retaining its position as India's best-selling drug for the fifth consecutive month at 117 crore in February sales

While this is a major victory for Novo Nordisk, manufacturer of Wegovy and Ozempic, the battle to end the compounding of these products isnt over just yet